Fig. 4From: Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulationsMost inactive compound (IC50 = 45,000) aligned to only three featuresBack to article page